TETRAHYDROISOCHINOLINDERIVATE

European patent · EP3204359 · In force

Register entry

Publication number
EP3204359
Application number
EP15775688
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 6, 2015
Published
Aug 16, 2017
Granted
Jul 1, 2020
Protection ends at the latest
Oct 5, 2035
Next annual fee due
Oct 31, 2027
IPC classes
C07D 217/06 (2006.01)
A61K 31/472 (2006.01)
A61K 31/4725 (2006.01)
C07D 401/06 (2006.01)
C07D 403/06 (2006.01)
C07D 413/04 (2006.01)
Priority
EP 14188174 08.10.2014
PCT application
PCT/EP2015/073053 06.10.2015
PCT publication
WO2016/055479 14.04.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.10.2026 → 31.10.2027

    Published in Swissreg on 01.11.2026

  2. Nov 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.10.2025 → 31.10.2026

    Published in Swissreg on 01.11.2025

  3. Nov 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.10.2024 → 31.10.2025

    Published in Swissreg on 01.11.2024

  4. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  5. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  6. Jul 1, 2020

    Granted

    Published in Swissreg on 01.07.2020

Parties

Holder

UCB Biopharma SRL

Allée de la Recherche 60, 1070 Brussels, BE

Inventor

SANDS, Zara

B-1070 Brussels, BE

ATES, Ali

B-1070 Brusssels, BE

MATHIEU, Benoît

B-1070 Brussels, BE

SKOLC, David

B-1070 Brussels, BE

JNOFF, Eric

B-1070 Brussels, BE

BURSSENS, Pierre

B-1070 Brussels, BE

VALADE, Anne

B-1070 Brussels, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.